|
| Issue Date | Title | Author(s) |
| Jun-2018 | Caffeic acid phenethyl ester guards against benign prostate hypertrophy in rats: Role of IGF-1R/protein kinase-B (Akt)/β-catenin signaling | Omar, Hany A; Tolba, Mai |
| 1-Jun-2017 | Caffeic acid phenethyl ester protects against glucocorticoid-induced osteoporosis in vivo: Impact on oxidative stress and RANKL/OPG signals | Tolba, Mai ; El-Serafi, Ahmed T; Omar, Hany A |
| 2-Oct-2016 | Caffeic Acid Phenethyl Ester: A Review of Its Antioxidant Activity, Protective Effects against Ischemia-reperfusion Injury and Drug Adverse Reactions | Tolba, Mai ; Omar, Hany A; Azab, Samar S; Khalifa, Amani E; Abdel-Naim, Ashraf B; Abdel-Rahman, Sherif Z |
| Dec-2014 | Design, synthesis and biological evaluation of novel diphenylthiazole-based cyclooxygenase inhibitors as potential anticancer agents | Abdelazeem, Ahmed H; Gouda, Ahmed M; Omar, Hany A; Tolba, Mai |
| Sep-2019 | Immunomodulatory MicroRNAs in cancer: targeting immune checkpoints and the tumor microenvironment | Omar, Hany A; El-Serafi, Ahmed T; Hersi, Fatema; Arafa, El-Shaimaa A; Zaher, Dana M; Madkour, Mohamed; Arab, Hany H; Tolba, Mai |
| Feb-2018 | Immunotherapy, an evolving approach for the management of triple negative breast cancer: Converting non-responders to responders | Tolba, Mai ; Omar, Hany A |
| 15-May-2019 | The impact of Catechol-O-methyl transferase knockdown on the cell proliferation of hormone-responsive cancers | Tolba, Mai ; Omar, Hany A; Hersi, Fatima; Nunes, Ane C F; Noreddin, Ayman M |
| 1-May-2021 | Nuclear factor-κB signaling inhibitors revert multidrug-resistance in breast cancer cells | Abdin, Shifaa M; Tolba, Mai ; Zaher, Dana M; Omar, Hany A |
| 2016 | OSU-2S/Sorafenib Synergistic Antitumor Combination against Hepatocellular Carcinoma: The Role of PKCδ/p53 | Omar, Hany A; Tolba, Mai ; Hung, Jui-Hsiang; Al-Tel, Taleb H |
| Dec-2014 | Potential targets of energy restriction mimetic agents in cancer cells | Omar, Hany A; Tolba, Mai ; Saber-Ayad, Maha M |
| Mar-2019 | Tackling molecular targets beyond PD-1/PD-L1: Novel approaches to boost patients' response to cancer immunotherapy | Omar, Hany A; Tolba, Mai |
